陈天桥再次押注！中国首家超声脑机接口公司格式塔 Gestala 正式成立，开启全脑读写脑机接口时代

Core Viewpoint - Gestala (Chengdu) Technology Co., Ltd. has officially launched as China's first company focused on ultrasound brain-machine interface technology, aiming to provide innovative solutions for brain disease treatment and neuroscience research through non-invasive ultrasound technology [1][2][3]. Company Overview - Gestala was co-founded by Peng Lei, former co-founder and CEO of Brain Tiger Technology, and Chen Tianqiao, founder of Shanda Group and Tianqiao Brain Science Research Institute, focusing on the innovation of ultrasound brain-machine interface technology [3][5]. - The company is located in Chengdu's Tianfu International Biological City and has also established a presence in Shanghai's Brain Intelligence World, a hub for brain-machine interface industries [3]. Technology and Applications - Gestala's ultrasound technology features non-invasive, high spatiotemporal resolution, and full-brain coverage, targeting clinical interventions for central nervous system diseases such as chronic pain, depression, and Alzheimer's disease [1][6]. - The ultrasound brain-machine interface is expected to enable precise modulation of specific brain regions without the need for surgery, allowing for innovative treatments and exploration of new targets for related brain diseases [6][8]. - The company plans to launch its first magnetic resonance-guided device for chronic pain management and initiate the NMPA registration process by the end of 2026 [8]. Clinical Collaborations and Research - Gestala has established collaborative frameworks with top hospitals such as Huashan, Xiehe, and Huaxi, aiming to deepen the synergy between industry, academia, and clinical research [8][11]. - The company has reported significant clinical intervention results in chronic pain management and depression, with effects lasting up to seven days after treatment [8]. Market Potential and Competitive Landscape - The global ultrasound brain-machine interface financing boom positions China to potentially "leapfrog" in this field, with significant investments flowing into ultrasound technology as a disruptive alternative to invasive methods [9][10]. - The ultrasound route is gaining traction due to its ability to cover 25% of the brain volume, compared to traditional invasive methods that are limited to localized areas [7][11]. - Gestala's interdisciplinary team includes experts from neuroscience, AI, ultrasound engineering, and clinical medicine, enhancing its capability for research breakthroughs and clinical applications [11].